三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
截至2024年6月末,国内血制品企业尚未能生产的血源性血制品品种
截至2024年6月末,国内血制品企业尚未能生产的血源性血制品品种
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:238KB
图片尺寸:2291*1451
同报告图片
/
4
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
fCDlubTku70gfCDph4fmtYbph4/vvIjlkKjvvIkgfCDph4fmtYbph495b3kgfAp8IC0tLSB8IC0tLSB8IC0tLSB8CnwgMjAxOCB8IDM1MCB8IC0gfAp8IDIwMTkgfCAzNzAgfCAtIHwKfCAyMDIwIHwgMzgwIHwgLSB8CnwgMjAyMSB8IDQyMCB8IC0gfAp8IDIwMjIgfCA0NTAgfCAtIHwKfCAyMDIzIHwgNDcwIHwgLSB8CnwgMjAyNEgxIHwgMjUwIHwgLSB8CgrotYTmlpnmnaXmupDvvJrljZrpm4XnlJ/nianlhazlj7jlhazlkYrvvIzlpKrlubPmtIvor4HliLjmlbTnkIY=
fCDlubTku70gfCDlnKjov5DokKXmtYbnq5kgfCDlnKjlu7rmtYbnq5kgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tfAp8IDIwMTggfCAxMiAgICAgICAgIHwgMCAgICAgICAgfAp8IDIwMTkgfCAxMiAgICAgICAgIHwgMCAgICAgICAgfAp8IDIwMjAgfCAxMyAgICAgICAgIHwgMCAgICAgICAgfAp8IDIwMjEgfCAxNCAgICAgICAgIHwgMCAgICAgICAgfAp8IDIwMjIgfCAxNCAgICAgICAgIHwgMCAgICAgICAgfAp8IDIwMjMgfCAxNCAgICAgICAgIHwgMiAgICAgICAgfAp8IDIwMjRIMSB8IDE0ICAgICAgICAgfCAyICAgICAgICB8CgrotYTmlpnmnaXmupDvvJrljZrpm4XnlJ/nianlhazlj7jlhazlkYrvvIzlpKrlubPmtIvor4HliLjmlbTnkIY=
所属报告:
生物医药Ⅱ行业深度研究:以血制品行业盈利模型窥其投资价值几何-241201(61页).pdf
打包全文图表
相关数据
PCC与重组及血源性九因子产品对比
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
收藏
行业数据
2024-12-03
原图定位
查看详情
图11.2017年各地区血源性凝血因子VIII人均用量情况
收藏
行业数据
2021-04-06
原图定位
查看详情
图42.国内血源性凝血因子VIII批签发情况
收藏
行业数据
2021-04-06
原图定位
查看详情
图43.2017-2018企业血源性凝血因子VIII批签占比情况
收藏
行业数据
2021-04-06
原图定位
查看详情
表19.国内血源性凝血因子类产品及重组凝血因子产品
收藏
行业数据
2021-04-06
原图定位
查看详情
国内血源性FVIII历年批签发量
收藏
行业数据
2020-09-08
原图定位
查看详情
国内血源性FVIII历年批签发量
收藏
行业数据
2020-09-08
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
从长期来看,血制品企业的竞争力将从规模优势向品种优势及产品质量优势过渡,基于:(1)在我国血制品行业产品种类普遍较少的情况下,小产品的研发成功意味着企业能够进入竞争相对较少的细分市场,同时丰富的产品品类和规格能够增强企业在招标和集采过程中的竞争力和灵活性;(2)产品质量的提升不仅可以提高品牌认可度,带来差异化竞争优势,还关系到企业能否成功进入国际市场,因为符合海外的质量标准将是国际市场准入的关键因素。因此我们认为,加大投入研发,建立更高的质量标准,开发更具有竞争力和高附加值新品类,将成为企业的必然选择。
行业数据
原图定位
当前图表所属:
生物医药Ⅱ行业深度研究:以血制品行业盈利模型窥其投资价值几何-241201(61页).pdf
2026年血制品行业深度报告:采浆量2025年破15000吨,四代静丙与出海前景
规模较小的血制品企业往往经营困难,为头部企业进行并购提供了可行性
2018-2024H1博雅生物采浆量及同比增速
2018-2024H1博雅生物在营浆站及在建浆
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》